In the evolving domain of peptide-based bioengineering, TB-500 occupies a distinct conceptual position as a synthetic analog ...
A study links the high-risk CFH Y402H genotype to granzyme B activity, reduced vitronectin and membrane attack complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results